Intersectoral and integrated approaches in achieving the right to health for refugees on resettlement: a scoping review.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 07 2019
Historique:
entrez: 4 7 2019
pubmed: 4 7 2019
medline: 24 7 2020
Statut: epublish

Résumé

Better understanding, documentation and evaluation of different refugee health interventions and their means of health system integration and intersectoral collaboration are needed. Explore the barriers and facilitators to the integration of health services for refugees; the processes involved and the different stakeholders engaged in levaraging intersectoral approaches to protect refugees' right to health on resettlement. Scoping review. A search of articles from 2000 onward was done in MEDLINE, Web of Science, Global Health and PsycINFO, Embase. Two frameworks were applied in our analysis, the 'framework for analysing integration of targeted health interventions in systems' and 'Health in All Policies' framework for country action. A comprehensive description of the methods is included in our published protocol. 6117 papers were identified, only 18 studies met the inclusion criteria. Facilitators in implementation included: training for providers, colocation of services, transportation services to enhance access, clear role definitions and appropriate budget allocation and financing. Barriers included: lack of a participatory approach, insufficient resources for providers, absence of financing, unclear roles and insufficient coordination of interprofessional teams; low availability and use of data, and turf wars across governance stakeholders. Successful strategies to address refugee health included: networks of service delivery combining existing public and private services; system navigators; host community engagement to reduce stigma; translation services; legislative support and alternative models of care for women and children. Limited evidence was found overall. Further research on intersectoral approaches is needed. Key policy insights gained from barriers and facilitators reported in available studies include: improving coordination between existing programmes; supporting colocation of services; establishing formal system navigator roles that connect relevant programmes; establishing formal translation services to improve access and establishing training and resources for providers.

Sections du résumé

BACKGROUND
Better understanding, documentation and evaluation of different refugee health interventions and their means of health system integration and intersectoral collaboration are needed.
OBJECTIVES
Explore the barriers and facilitators to the integration of health services for refugees; the processes involved and the different stakeholders engaged in levaraging intersectoral approaches to protect refugees' right to health on resettlement.
DESIGN
Scoping review.
METHODS
A search of articles from 2000 onward was done in MEDLINE, Web of Science, Global Health and PsycINFO, Embase. Two frameworks were applied in our analysis, the 'framework for analysing integration of targeted health interventions in systems' and 'Health in All Policies' framework for country action. A comprehensive description of the methods is included in our published protocol.
RESULTS
6117 papers were identified, only 18 studies met the inclusion criteria. Facilitators in implementation included: training for providers, colocation of services, transportation services to enhance access, clear role definitions and appropriate budget allocation and financing. Barriers included: lack of a participatory approach, insufficient resources for providers, absence of financing, unclear roles and insufficient coordination of interprofessional teams; low availability and use of data, and turf wars across governance stakeholders. Successful strategies to address refugee health included: networks of service delivery combining existing public and private services; system navigators; host community engagement to reduce stigma; translation services; legislative support and alternative models of care for women and children.
CONCLUSION
Limited evidence was found overall. Further research on intersectoral approaches is needed. Key policy insights gained from barriers and facilitators reported in available studies include: improving coordination between existing programmes; supporting colocation of services; establishing formal system navigator roles that connect relevant programmes; establishing formal translation services to improve access and establishing training and resources for providers.

Identifiants

pubmed: 31266840
pii: bmjopen-2019-029407
doi: 10.1136/bmjopen-2019-029407
pmc: PMC6609038
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e029407

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Med. 2015 Apr 29;13:101
pubmed: 25925656
J Sch Nurs. 2010 Dec;26(6):430-5
pubmed: 20855533
Am J Public Health. 2005 Feb;95(2):196-9
pubmed: 15671449
Cochrane Database Syst Rev. 2014 Nov 11;(11):CD009317
pubmed: 25386846
Annu Rev Popul Law. 1989;16:175
pubmed: 12344222
Health Econ Policy Law. 2009 Apr;4(Pt 2):159-78
pubmed: 19187568
J Adv Nurs. 2010 Feb;66(2):350-9
pubmed: 20423418
Health Policy Plan. 2008 Sep;23(5):308-17
pubmed: 18701552
BMC Med Res Methodol. 2016 Feb 09;16:15
pubmed: 26857112
BMJ Glob Health. 2018 Oct 10;3(Suppl 4):e000970
pubmed: 30364329
Health Promot Int. 2014 Jun;29 Suppl 1:i19-28
pubmed: 25217354
Health Policy Plan. 2018 Sep 1;33(7):767-776
pubmed: 29905861
Public Health Nurs. 2002 May-Jun;19(3):191-200
pubmed: 11967105
Lancet. 2013 Apr 6;381(9873):1235-45
pubmed: 23541058
Health Policy Plan. 2010 Mar;25(2):104-11
pubmed: 19917651
Lancet. 2018 Dec 15;392(10164):2606-2654
pubmed: 30528486
J Paediatr Child Health. 2016 Jan;52(1):72-9
pubmed: 26416315
Health Policy. 2009 Oct;92(2-3):203-10
pubmed: 19403192
Med Confl Surviv. 2005 Jul-Sep;21(3):199-215
pubmed: 16180733
J Paediatr Child Health. 2010 Oct;46(10):560-7
pubmed: 20626581
BMJ Open. 2017 Aug 30;7(8):e016638
pubmed: 28855201
BMJ Glob Health. 2018 Oct 10;3(Suppl 4):e000880
pubmed: 30364411
BMC Med Res Methodol. 2008 Jul 10;8:45
pubmed: 18616818
Am J Public Health. 2017 Nov;107(11):1755-1756
pubmed: 29019787
Gen Hosp Psychiatry. 2004 Jul-Aug;26(4):256-60
pubmed: 15234819
J Immigr Minor Health. 2014 Aug;16(4):576-85
pubmed: 24293090
BMC Public Health. 2013 Mar 15;13:227
pubmed: 23497392
Int J Equity Health. 2013 Nov 07;12:88
pubmed: 24199588
Soc Sci Med. 2018 Feb;199:29-38
pubmed: 28410759
Hisp Health Care Int. 2009;7(4):179-189
pubmed: 20877438

Auteurs

Shirley Ho (S)

Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.

Dena Javadi (D)

Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.

Sara Causevic (S)

Swedish Institute for Global Health Transformation, Royal Swedish Academy of Sciences, Stockholm, Sweden.
Global and Sexual Health, Department of Public Health Sciences, Karolinska Institute, Stockholm, Sweden.

Etienne V Langlois (EV)

Alliance for Health Policy and Systems Research, World Health Organization, Geneva, Switzerland.

Peter Friberg (P)

Swedish Institute for Global Health Transformation, Royal Swedish Academy of Sciences, Stockholm, Sweden.
Institute of Medicine, Sahlgrenska Academy, Gothenburg, Sweden.

Göran Tomson (G)

Swedish Institute for Global Health Transformation, Royal Swedish Academy of Sciences, Stockholm, Sweden.
Medical Management Centre, Department of Learning, Informatics, Management, Ethics, Karolinska Institute, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH